NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









VectorBuilder

VectorBuilder

Private
Chicago, IllinoisHealthcare & Life Scienceshttps://en.vectorbuilder.com/

Last Round

Series C

Extension

Jul 26, 2023

Est. Valuation

$1B

Total Funding Raised

$76M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

VectorBuilder is a biotechnology company that provides a full spectrum of gene delivery solutions, including an online platform for vector design, custom cloning, virus packaging, and CDMO services for research and clinical applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Infrastructure

Keywords

gene deliveryviral vectormolecular cloningCDMOcontract development and manufacturing organizationAAVadeno-associated virusGMP manufacturingcapsid engineeringCRISPR librarystable cell linesynthetic biologypreclinical testingbiotech outsourcinggene therapy tools

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

VectorBuilder Comparables

Compare VectorBuilder with similar companies based on industry and business-model similarity.

VectorBuilder comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PackGene Biotech
88%
GenScript
84%
Charles River Laboratories
79%

VectorBuilder Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series C ExtensionJul 26, 2023
Series COct 1, 2022

VectorBuilder Investors

Notable investors and investment history

VectorBuilder investors
InvestorRounds
Legend CapitalSeries C
Guangzhou Yuexiu Industrial Investment Fund ManagementSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 3, 2026

    Attending the ARVO Annual Meeting in Denver, Colorado.

  • Apr 14, 2026

    Launched MuteFree AAV for gene therapy development.

VectorBuilder Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

VectorBuilder Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about VectorBuilder's valuation, stock price, and market status.

Firmographic Details

HeadquartersChicago, Illinois
Employee Range107
Year Founded2014
Last FundingJul 26, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.